In a study, women who chose AI-powered mammograms were 21% more likely to have cancer detected than those who didn’t.
Pharmac will also fund osimertinib for people with a type of advanced non-small cell lung cancer. About 20 percent of people with non-small cell lung cancer have a mutation in their cancer that can be ...
A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.
A breast cancer drug - which keeps the disease stable for up to four times longer than the previous treatment - will be publicly funded from next month.
Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. If you’re covering the American Society of Hematology (ASH) Annual Meeting, Dec. 7-10 in San ...
WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news ...
Tumors and other cancers can shed DNA into the bloodstream, distorting the ratios. Sometimes this can lead to alarming ...
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
A study from researchers at the University of Michigan and the University of California San Diego has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...
When Julie Durbin was undergoing cancer treatment, she was always cold. She would bring a cardigan, a sweater that opens in ...
In February 2020, NERLYNX was also approved by the FDA in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received ...